Kintara Therapeutics Inc. sell bundfuture
Start price
01.12.22
/
50%
€8.82
Target price
01.12.23
-
Performance (%)
57.03%
End price
10.12.22
€13.85
Summary
This prediction ended on 10.12.22 with a price of €13.85. The price for Kintara Therapeutics Inc. massively increased, which is bad news for the SELL prediction by bundfuture. bundfuture has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Kintara Therapeutics Inc. | -16.887% | -16.887% | -96.168% |
| iShares Core DAX® | -1.822% | -1.170% | 11.771% |
| iShares Nasdaq 100 | -0.241% | 1.961% | 40.760% |
| iShares Nikkei 225® | -2.310% | -1.758% | 21.493% |
| iShares S&P 500 | -0.835% | 1.309% | 28.068% |
According to bundfuture what are the pros and cons of Kintara Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by bundfuture for this prediction
In the thread Kintara Therapeutics Inc. diskutieren
Sell Kintara Therapeutics Inc.